Saatchi reportedly wins Levitra DTC work

Share this article:

The Saatchi & Saatchi Consumer Healthcare unit of Publicis Groupe has won the creative duties for Levitra, AdWeek.com reported late Thursday.
Levitra, which is now co-promoted by Schering-Plough and GlaxoSmithKline, has been in review for the past several weeks.
CommonHealth's Quantum previously held the account, but was not listed among the groups who were pitching. A spokeswoman for CommonHealth declined to comment to MM&M about the review this week
Estimated billings are $90 million.
The other finalists were Omnicom Group shops BBDO and Merkley + Partners, both in New York, according to AdWeek. DDB, another Omnicom shop, initially pursued the business but withdrew before final presentations, the report stated.
Bayer and GSK co-promoted Levitra since its launch in 2003, but earlier this year Bayer agreed to turn over marketing rights for most of its prescription drug products to Schering-Plough.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.